Therapeutics against DNA-damage-mediated neurodegeneration in PD have been attempted by chemically inhibiting ATM, an important kinase in the repair cascade responsible for phosphorylating H2AX and repair proteins such as 53BP1 [112,113,114]. Here, H2AX is linked to Parkinson disease.